Panacos Pharmaceuticals Stock Performance
| PANC Stock | USD 0.0001 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Panacos Pharmaceuticals are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Panacos Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Panacos Pharmaceuticals is not utilizing all of its potentials. The recent stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Last Split Factor 1:10 | Last Split Date 2005-03-15 |
Panacos Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 0.01 in Panacos Pharmaceuticals on September 29, 2025 and sell it today you would earn a total of 0.00 from holding Panacos Pharmaceuticals or generate 0.0% return on investment over 90 days. Panacos Pharmaceuticals is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Panacos, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Panacos Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Panacos Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Panacos Pharmaceuticals, and traders can use it to determine the average amount a Panacos Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| PANC |
Based on monthly moving average Panacos Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Panacos Pharmaceuticals by adding Panacos Pharmaceuticals to a well-diversified portfolio.
Panacos Pharmaceuticals Fundamentals Growth
Panacos Stock prices reflect investors' perceptions of the future prospects and financial health of Panacos Pharmaceuticals, and Panacos Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Panacos Stock performance.
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.53 | ||||
| Operating Margin | (315.46) % | ||||
| Current Valuation | 321.84 K | ||||
| Price To Earning | (1.33) X | ||||
| Price To Sales | 3.25 X | ||||
| Revenue | 180 K | ||||
| Gross Profit | 99 K | ||||
| EBITDA | (33.84 M) | ||||
| Net Income | (37.46 M) | ||||
| Cash And Equivalents | 26.89 M | ||||
| Cash Per Share | 0.50 X | ||||
| Total Debt | 358 K | ||||
| Debt To Equity | 3.45 % | ||||
| Current Ratio | 2.15 X | ||||
| Book Value Per Share | 0.1 X | ||||
| Cash Flow From Operations | (31.04 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Market Capitalization | 321.84 K | ||||
| Total Asset | 55.71 M | ||||
| Retained Earnings | (160.02 M) | ||||
| Working Capital | 14.7 M | ||||
| Current Asset | 27.52 M | ||||
| Current Liabilities | 12.82 M | ||||
About Panacos Pharmaceuticals Performance
By analyzing Panacos Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Panacos Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Panacos Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Panacos Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 22.20 | 26.37 | |
| Return On Tangible Assets | (0.77) | (0.81) | |
| Return On Capital Employed | 0.76 | 0.62 | |
| Return On Assets | (0.77) | (0.81) | |
| Return On Equity | (1.49) | (1.42) |
Things to note about Panacos Pharmaceuticals performance evaluation
Checking the ongoing alerts about Panacos Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Panacos Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Panacos Pharmaceuticals generated a negative expected return over the last 90 days | |
| Panacos Pharmaceuticals has some characteristics of a very speculative penny stock | |
| Panacos Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 180 K. Net Loss for the year was (37.46 M) with profit before overhead, payroll, taxes, and interest of 99 K. | |
| Panacos Pharmaceuticals currently holds about 26.89 M in cash with (31.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Panacos Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Panacos Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Panacos Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Panacos Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Panacos Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Panacos Pharmaceuticals' stock. These opinions can provide insight into Panacos Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Panacos Stock analysis
When running Panacos Pharmaceuticals' price analysis, check to measure Panacos Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panacos Pharmaceuticals is operating at the current time. Most of Panacos Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Panacos Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panacos Pharmaceuticals' price. Additionally, you may evaluate how the addition of Panacos Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |